Modulation of Antithrombin-Protease Interactions by Semisynthetic Low-Molecular-Weight Heparins with Different Sulfation Patterns

ABSTRACT

Heparin, a natural glycosaminoglycan (GAG), is widely used for the treatment of thrombotic diseases. Most of its side effects are related to its ability to bind to different proteins, thus interfering with its target biological activity. To gain insight into structure-activity relationships, we investigated the interaction of a homogeneous series of sulfated polysaccharides, derived from controlled desulfation of a supersulfated low-molecular-weight heparin (LMWH) with the target enzymes human antithrombin (AT) and thrombin (T). In addition, we analyzed the activation process of the serpin AT against T and factor Xa (FXa). A nonlinear correlation between the strength of the AT-heparin complex and the polysaccharide sulfation degree was observed, whereas only a modest modulation of T binding to heparin occurred. The efficiency of the LMWH derivatives in activating AT toward the proteases was generally high for derivatives exhibiting a low dissociation constant. Only the supersulfated heparin showed a serpin activation ability higher than expected from the affinity studies.

Examination of the sulfation pattern in the light of the above results suggests a key role of the substitution of the iduronic acid residue in the heparin-mediated serpin binding and activation processes. Indeed, sulfation at position 2 of the uronic acid is beneficial, whereas 2,3-disubstitution generates unfavorable contacts between the GAG and AT. Glucosamine sulfation at position 6 appears to grant increased catalytic efficiency.

These results indicate that chemical modification of the heparin sulfation pattern can be used to modulate binding specificity and activity toward its biological targets.

KEYWORDS

Glycosaminoglycan - heparin - antithrombin - thrombin - sulfation - polysaccharide

REFERENCES

• 1 Hirsh J. Heparin.  N Engl J Med . 1991;  324 1565-1574
• 2 Kjellen L, Lindahl U. Proteoglycans: structures and interactions.  Annu Rev Biochem . 1991;  60 443-475
• 3 Casu B, Lindahl U. Structure and biological interactions of heparin and heparan sulfate.  Adv Carbohydr Chem Biochem . 2001;  57 159-206
• 4 Rosenberg R D, Lam L. Correlation between structure and function of heparin.  Proc Natl Acad Sci U S A . 1979;  76 1218-1222
• 5 Gettings P GW, Patson P A, Olson S T. Serpins: Structure, Function and Biology.  Austin, TX: RG Landes; 1996
• 6 Desai R U, Petitou M, Bjork I, Olson S T. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.  Biochemistry . 1998;  37 13033-13041
• 7 Carrell R W, Evans D L, Stein P E. Mobile reactive centre of serpins and the control of thrombosis.  Nature . 1991;  353 576-578
• 8 Huntington J A, Olson S T, Fan B, Gettins P GW. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.  Biochemistry . 1996;  35 8495-8503
• 9 Lin L, Abrahams J P, Skinner R, Petitou M, Pike R N, Carrell R W. The anticoagulant activation of antithrombin by heparin.  Proc Natl Acad Sci U S A . 1997;  94 14683-14688
• 10 Capila I, Linhardt R J. Heparin-protein interactions.  Angew Chem Int Ed Engl . 2002;  41 391-412
• 11 Casu B, Oreste P, Torri G. et al . The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.  Biochem J . 1981;  197 599-609
• 12 Lindahl U, Backstrom G, Hook M, Thunberg L, Fransson L A, Linker A. Structure of the antithrombin-binding site in heparin.  Proc Natl Acad Sci U S A . 1979;  76 3198-3202
• 13 Atha D H, Lormeau J C, Petitou M, Rosenberg R D, Choay J. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.  Biochemistry . 1987;  26 6454-6461
• 14 Torri G, Casu B, Gatti G. et al . Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue.  Biochem Biophys Res Commun . 1985;  128 134-140
• 15 Lei P S, Duchaussoy P, Sizun P, Mallet J M, Petitou M, Winay P. Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence.  Bioorg Med Chem . 1998;  6 1337-1346
• 16 Casu B, Naggi A, Torri G. Modulation of sulfation patterns of glycosaminoglycans. In: Thiem J, ed. Glycoscience Heidelberg: Springer Verlag; 2000: 1895-1904
• 17 Naggi A, Decristofano B, Bisio A, Torri G, Casu B. Generation of antifactor Xa active 3O-sulfated glucosamine rich sequences by controlled desulfation of oversulfated heparins.  Carbohydr Res . 2001;  336 283-290
• 18 Naggi A, Torri G, Casu B. et al . Supersulfated heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties.  Biochem Pharmacol . 1987;  36 1895-1900
• 19 Nordenman B, Nystrom C, Björk I. The size and shape of human and bovine antithrombin III.  Eur J Biochem . 1977;  78 195-203
• 20 Olson S T. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.  J Biol Chem . 1988;  263 1698-1708
• 21 Jesty J, Esnouf M P. The preparation of activated factor X and its action on prothrombin.  Biochem J . 1973;  131 791-799
• 22 Olson S T, Björk I, Shore J D. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.  Methods Enzymol . 1993;  22 525-559
• 23 Manning G S. Radius of the elastic rod model of a polyelectrolyte.  Biopolymers . 1972;  11 937-949
• 24 Olson S T, Halvorson H R, Björk I. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models.  J Biol Chem . 1991;  266 6342-6352
• 25 Evans S A, Olson S T, Shore J D. p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases.  J Biol Chem . 1982;  257 3014-3017
• 26 Einarsson R, Andersson L O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.  Biochim Biophys Acta . 1976;  490 104-111
• 27 Dunn M J, Waker J M. In: The Protein Protocols Handbook Totowa, NJ: Humana Press 1996: 229-234
• 28 Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.  Nature . 1970;  227 680-685
• 29 Einarsson R, Andersson L O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.  Biochim Biophys Acta . 1976;  490 104-111
• 30 Sissi C, Naggi A, Torri G, Palumbo M. Effects of sulfation on antithrombin-thrombin/Factor Xa interactions in semisynthetic low-molecular-weight heparins Semin Thromb Hemost .  2001;  27 483-487
• 31 Ersdal-Badju E, Lu A, Zuo Y, Picard V, Bock S C. Identification of the antithrombin III heparin binding site.  J Biol Chem . 1997;  272 19393-19400
• 32 Sissi C, Lucatello L, Naggi A, Torri G, Palumbo M. Effects of Ca²⁺ ions on the interactions between antithrombin III and factor Xa mediated by variously-sulfated semi-synthetic low-molecular-weight heparins Semin Thromb Hemost .  2002;  28 355-360
• 33 Evington J RN, Feldman P A, Luscombe M, Holbrook J J. Multiple complexes of thrombin and heparin.  Biochim Biophys Acta . 1986;  871 85-92
• 34 Rezaie A R. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.  J Biol Chem . 1998;  273 16824-16827
• 35 Petitou M, Herault J P, Bernat A. et al . Synthesis of thrombin-inhibiting heparin mimetics without side effects.  Nature . 1999;  398 417-422